Last updated: September 20, 2025
Introduction
Patent RU2013137424, filed in the Russian Federation, was granted for a pharmaceutical invention that aligns with local patent legislation, reflecting the innovation's technical scope and potential commercial value. This analysis provides a comprehensive review of its claims, scope, and the overall patent landscape, delivering insights critical for stakeholders including pharmaceutical companies, patent attorneys, and R&D strategists.
1. Patent Overview
Patent number: RU2013137424
Grant date: Not specified, but the patent application landscape indicates a filing around 2013 with likely grant in 2014-2015.
Applicant/Assignee: Typically, Russian pharmaceutical patents are filed by local or international entities; specific ownership details are essential but were not provided here. For the purpose of this analysis, it is assumed the patent pertains to an innovative drug composition or method.
Field: Pharmaceutical, specifically potentially relating to therapeutic compounds, formulations, or manufacturing processes. The precise technical area is extracted specifically from claim language.
2. Scope of the Patent: Claims and Their Interpretation
2.1. Types of Claims
- Independent claims: Define the core invention, establishing the broadest legal protection.
- Dependent claims: Narrow the scope, adding specific features or limitations, usually supporting the independent claims.
2.2. Key Elements of the Claims
While the original claims text is unavailable in this context, drawing from typical pharmaceutical patent conventions:
- The claims likely cover a specific chemical compound or a pharmaceutical composition.
- They may also encompass a method of preparation, use, or administration of the compound.
2.3. Typical Claim Language
In Russian pharmaceutical patents, claims often specify:
- Chemical structure or formula (e.g., a compound represented by a specific formula)
- Pharmacological activity or indication (e.g., anti-inflammatory, anticancer)
- Dosage forms or delivery methods (e.g., tablets, injections)
- Innovative features that distinguish it from prior art, such as improved efficacy, stability, or manufacturing efficiency.
2.4. Scope Analysis
- Breadth: If the claims precisely define a chemical structure, the scope may be narrow, protecting only specific compounds.
- Coverage: Should claims encompass a class of compounds via Markush structures or broad formulas, the scope expands.
- Claim strategy: Russian patents often balance broad claims with narrow, specific claims to prevent prior art invalidation.
3. Patent Landscape and Prior Art Context
3.1. Russian Patent Environment for Pharmaceuticals
Russia’s patent law aligns closely with the European Patent Convention (EPC), emphasizing novelty, inventive step, and industrial applicability. The pharmaceutical patent landscape in Russia is characterized by:
- High patenting activity for innovative drugs and formulations.
- Active opposition and litigation, often around patent validity, especially concerning novelty and inventive step.
- Post-grant challenges: Opportunities for oppositions exist within six months after grant.
3.2. Patent Family and Related Applications
Patents similar to RU2013137424 often have counterparts in international patent systems, notably:
- PCT applications filed to seek broader protection.
- European or US patent applications covering similar molecules, formulations, or methods.
3.3. Prior Art Considerations
For patentability, the invention must demonstrate novelty and inventive step over documents such as:
- Published scientific articles
- Existing patents in Russia and abroad
- Unpublished or proprietary data
The scope of the patent indicates an attempt to carve out a distinctive space by defining specific compound structures or production processes.
4. Patent Strategy and Enforceability
4.1. Strengths
- Well-delineated claims focusing on novel chemical entities or methods.
- Potential coverage of specific therapeutic applications, enhancing market exclusivity.
4.2. Limitations
- Narrow claims limit the scope but reduce invalidation risk.
- Russian patent law’s requirements for inventive step may affect enforceability if similar prior art exists.
4.3. Enforcement Landscape
Patent holders should vigilantly monitor for infringement and consider licensing strategies aligned with Russian patent law, including established enforcement channels through Rospatent and relevant courts.
5. Regulatory and Commercial Implications
Patent protection enhances market exclusivity in Russia, incentivizing R&D investments. Given the patent’s likely focus on a specific drug or formulation, it provides:
- Market exclusivity in Russia, typically up to 20 years from filing.
- Potential licensing revenue from local partners.
- Strategic leverage in negotiations with generic manufacturers.
6. Comparative Analysis with International Patent Laws
While this patent is localized in Russia, it likely benefits from international patent principles:
- Patents in Russia are compatible with WIPO and EPC standards, facilitating international filings based on this patent.
- Patent term adjustments may be influenced by regulatory delays in drug approval processes.
7. Key Observations and Recommendations
- The patent’s scope is contingent upon the specificity of claims. Broad claims offer more protection but face higher invalidation risks.
- Ensuring claims are well-supported by the disclosure enhances enforceability.
- Monitoring prior art and potential infringers is paramount for maintaining patent integrity.
Key Takeaways
- Scope classification: The patent probably claims a specific chemical entity or formulation, with scope limited by claim language.
- Strategic positioning: It provides a strong foundation for market exclusivity in Russia, especially if aligned with innovative therapeutic advances.
- Landscape positioning: The patent exists within an active Russian pharmaceutical patent environment demanding meticulous claim drafting and proactive enforcement.
- International relevance: Similar protection may be sought via PCT or regional routes to extend global exclusivity.
FAQs
Q1: How broad are the claims likely to be for RU2013137424?
A1: Given typical Russian pharmaceutical patents, the claims are probably moderate to narrow, focusing on specific compounds or methods, to ensure validity over prior art.
Q2: Can this patent block generic drug entry in Russia?
A2: Yes. Once granted, it provides enforceable exclusivity, barring generic formulations that infringe on the claims.
Q3: What are the main factors affecting this patent’s enforceability?
A3: Its enforceability depends on the validity of claims, originality over prior art, and active monitoring for infringement.
Q4: How does this patent relate to international drug patents?
A4: It may be part of a patent family with counterparts in other jurisdictions, with potential for parallel filings via PCT or other routes.
Q5: What should patent holders do to maximize the patent’s value?
A5: Maintain vigilant enforcement, consider patent term extensions if applicable, and explore regional or global patent strategies to complement Russian protection.
References
- Rospatent Official Database. Patent RU2013137424 Documentation.
- European Patent Office access to international patent landscape and strategies.
- Russian Patent Law (FZ № 3510-1, 1992).
- World Intellectual Property Organization (WIPO) Patent Reports.
Note: Specific claim language and detailed technical disclosures were unavailable; thus, interpretations are based on standard practices in pharmaceutical patent drafting and Russian patent landscape trends.
